South African e-health startup VitruvianMD has bagged an eight-figure ZAR so at least ZAR 10mn (US$659k) funding rounds to scale its technology and launch more pilot projects.
“The core of our business is to provide AI-based diagnostic software in areas with insufficient resources and to date, we have built a platform that enables this in various fields of disease. To further facilitate access, we have also developed a low-cost, high-quality camera that can adapt any microscope instantly enabling digital telepathology, “Ifthakaar Shaik, co-founder, and CEO of VitruvianMD stated.
“Our platform is robust enough to be used in any form of microscopy-based diagnostics and is proven by our pilots in hematology, histopathology, fertility, and parasitology.”
VitruvianMD’s eight-figure ZAR funding round was led by the Singapore-based company Verge Healthtech Fund and also features a number of angelic investors. It will be used to accelerate the development of the startup’s technology and to finance the launch of further pilot projects.
How to raise $1,000,000 million+ through Venture Financing
“With this funding, the goal is to reach commercialization of at least one of our diagnostic modules within the next 18 months,” said Shaik.
What You Need To Know About VitruvianMD
Founded last year, Vitruvian MD combines biomedical engineering and cutting-edge artificial intelligence (AI) to provide affordable, high-precision diagnostic tools for medical laboratories, with a focus on serving emerging markets.
Read the original article here
